Corporate Overview
Our Mission
Management Team
Board of Directors
Scientific Advisory Board
Investors
Our Technology
Closed Loop Technology
Ribosome Crystallography
Computational Methodology
Multidisciplinary Team
About the Ribosome
Newsroom
Press Releases
Rib-X in the News
Press Contacts
Careers
Current Opportunities
Benefits
About New Haven
More Information
Contact Us
Request Information
Directions to Rib-X
Corporate Overview
٠
Our Mission
٠
Management Team
٠
Board of Directors
٠
Scientific Advisory Board
٠
Investors
Investors
For investor information please contact:
Robert A Conerly CFO
Rib-X Pharmaceuticals
300 George Street, Suite 301
New Haven, CT 06511
Phone: 203.624.5606
Fax: 203.624.5627
bconerly@rib-x.com
Matthew Duch
FD
88 Pine Street, 32nd Floor
New York, NY 10005 212.850.5758
matthew.duch@fd.com
Investors:
ABS Ventures
Axiom Venture Partners LP
Cardinal Partners
Connecticut Innovations
EuclidSR Partners
MedImmune Ventures Inc.
Oxford Bioscience Partners
Radius Ventures LLC
SR One Venture Investments
Warburg Pincus LLC
Zero Stage Capital
